Skip to content
Ajooni Biotech logo

Ajooni Biotech

AJOONI NSE
₹2.95 up 0.01 (0.34%)
Market Cap
₹50.81 Cr
P/E
12.83

Ajooni Biotech (AJOONI) share price was ₹2.94 at the 28 Oct 2026 close; market capitalisation ₹50.64 Cr; P/E (TTM) 12.78; sector FMCG. The share price fell 43.2% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 103.0% year on year to ₹63.49 Cr and net profit fell 44.9% year on year to ₹0.43 Cr (compared with Jun 2025). Promoters held 30.53% of Ajooni Biotech in Sep 2026, up 3.64 percentage points from Jun 2026. Its Tapetide Score is 52/100 (Average) as of 28 Oct 2026.

Close 28 Oct 2026 ₹2.94 −2.26 −43.46% 1Y

Key Fundamentals

MicrocapFood ProductsFMCG
Market Cap
₹50.81 Cr
P/E (TTM)
12.83
EBITDA
₹8.70 Cr
Return on Equity
4.74%
Debt to Equity
0.2
Book Value
₹5.24
EPS (TTM)
₹0.23
52W High
₹5.50
52W Low
₹2.68

Price-based figures as of 29 Oct 2026, 10:43 IST · EPS basis: Standalone · TTM

Peer Comparison

Fast Moving Consumer Goods › FMCG › Food - Processing - Indian › Animal Feed

Godrej Agrovet
₹578.2524.9011,126 Cr5.471.88%20.58%23.15%10,601 Cr424 Cr
Avanti Feeds
₹672.2017.259,158 Cr2.791.49%17.68%23.53%6,587 Cr587 Cr
Mukka Proteins
₹24.6810.68740 Cr1.480.00%10.80%22.50%1,744 Cr74 Cr
Shivam Chemicals
—242.17247 Cr5.930.00%14.87%21.72%83 Cr1 Cr
Mayank Cattle Food
——136 Cr3.570.00%15.77%28.85%180 Cr2 Cr
Narmada Agrobase
₹11.4223.7987 Cr1.780.00%6.50%9.98%68 Cr4 Cr
Ajooni Biotech (this company)
₹2.9512.8351 Cr0.560.00%4.74%6.99%217 Cr4 Cr
Median 7 companies₹24.6820.52247 Cr2.790.00%14.87%22.50%217 Cr4 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

52 Average
Overall score

Data confidence 100/100

Category scores

Quality Weak 43
Returns, margins, earnings quality 22% weight
Valuation Average 50
Cheap vs sector & own history 24% weight
Growth Strong 98
Sales & profit trajectory 9% weight
Financial Health Strong 69
Solvency, leverage, coverage 9% weight
Momentum Poor 15
Trend strength, vol-adjusted 12% weight
Ownership Average 50
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

4
  • Stock is trading at 0.57 times its book value
  • Company is expected to give good quarter
  • Debtor days have improved from 48.9 to 35.8 days.
  • Company's working capital requirements have reduced from 128 days to 92.8 days

Weaknesses

3
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding is low: 30.5%
  • Company has a low return on equity of 4.02% over last 3 years.

Technical Indicators

Oscillators

Neutral

Bearish
2
Neutral
5
Bullish
2

Overall

Bearish

Bearish
12
Neutral
5
Bullish
2

Moving Averages

Bearish

Bearish
10
Neutral
0
Bullish
0

Growth Rate

Revenue Growth
58.22% higher than 3Y

change over 1 year

Net Income Growth
26.47% lower than 3Y

change over 1 year

Cash Flow Change
82.08%

change over 1 year

EBITDA Margin Change
-4.87%

change over 1 year Operating margin 2.63% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
21
19.48
20.05
19.58
25.66
25.72
34.03
29.27
31.27
31.74
58.75
60.62
63.49
Expenses
20.34
18.85
20.7
17.99
24.7
24.95
33.1
28.26
30.56
30.24
55.72
59.61
61.82
Operating Profit
0.66
0.63
-0.65
1.59
0.96
0.77
0.93
1.01
0.71
1.5
3.03
1.01
1.67
OPM %
3.14%
3.23%
-3.24%
8.12%
3.74%
2.99%
2.73%
3.45%
2.27%
4.73%
5.16%
1.67%
2.63%
Other Income
0.07
0.29
1.57
0.26
0.04
0.31
0.39
1.34
0.65
0.15
0.32
1.3
0.27
Interest
0.13
0.19
0.12
0.11
0.15
0.06
0.07
0.06
0.08
0.17
0.18
0.29
0.48
Depreciation
0.21
0.21
0.21
0.24
0.22
0.23
0.24
0.38
0.25
0.25
0.81
0.9
0.8
PBT
0.39
0.52
0.59
1.5
0.63
0.79
1.01
1.91
1.03
1.23
2.36
1.12
0.66
Tax %
-2.56%
23.08%
23.73%
38.67%
25.4%
22.78%
27.72%
19.37%
24.27%
24.39%
30.08%
15.18%
34.85%
Net Profit
0.4
0.4
0.44
0.91
0.47
0.62
0.73
1.54
0.78
0.93
1.65
0.95
0.43
EPS (₹)
0.02
0.02
0.03
0.05
0.03
0.04
0.04
0.09
0.05
0.05
0.1
0.06
0.02
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
7
13
29
42
40
40
51
74
74
80
115
182
215
Expenses
7
13
28
41
39
39
49
71
72
78
111
175
207
Operating Profit
0
0
1
1
1
1
2
3
3
2
4
6
7
OPM %
1.8%
1.7%
2.4%
2.2%
1.7%
3.1%
3.2%
4.2%
3.7%
2.8%
3.2%
3.4%
3.4%
Other Income
0
0
0
0
0
0
0
0
0
2
2
2
2
Interest
0
0
0
0
0
0
1
1
0
1
0
1
1
Depreciation
0
0
0
0
0
0
1
1
1
1
1
2
3
PBT
0
0
0
0
0
0
0
1
2
3
4
6
5
Tax %
27%
29%
28%
20%
15%
29%
26%
28%
28%
28%
22%
25%
—
Net Profit
0
0
0
0
0
0
0
1
1
2
3
4
4
EPS (₹)
0.05
0.06
0.13
0.03
0.03
0.02
0.02
0.05
0.06
0.12
0.2
0.25
0.23
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
0.24
0.24
0.33
6
6
8
10
10
18
18
34
34
Reserves
0
0
1
5
6
7
6
6
24
25
54
57
Borrowings
0
1
1
5
5
5
7
5
5
2
2
18
Other Liabilities
1
1
11
4
1
2
6
7
12
3
5
11
Total Liabilities
2
2
13
19
18
23
28
29
59
48
95
120
Fixed Assets
0
0
1
1
1
2
5
6
6
10
11
26
CWIP
0
0
0
0
0
0
0
0
0
1
0
0
Investments
0
0
6
6
4
3
1
1
4
2
3
2
Other Assets
1
2
6
12
13
18
22
22
48
34
80
92
Total Assets
2
2
13
19
18
23
28
29
59
48
95
120
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0
-1
-3
-3
-5
-4
1
4
-6
23
-32
-6
Investing
0
0
-2
0
1
0
-3
-2
-16
8
14
-16
Financing
0
1
5
8
-1
3
2
-2
22
-4
25
15
Net Cash Flow
0
0
0
5
-5
-1
0
0
0
27
6
-6
Free Cash Flow
0
-1
-3
-3
-5
-6
-2
2
-8
17
-33
-23
CFO/EBITDA
169
-257
-427
-284
-706
-353
71
125
-185
1,047
-845
-92
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
40
33
17
25
44
115
98
68
101
59
52
36
Inventory Days
22
14
63
19
51
34
46
34
39
80
90
97
Days Payable
66
27
79
9
12
20
46
39
56
8
13
22
Cash Conversion Cycle
-4
20
1
35
84
129
98
63
83
131
129
111
Working Capital Days
5
9
-29
-1
84
105
77
58
94
132
158
93
ROCE %
28%
18%
37%
10%
4%
4%
5%
9%
6%
8%
5%
6%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Ajooni Biotech insights

61 extracted metrics + investor summaries across FY15–FY27.

Shareholding Pattern

Public61.72%Others7.75%Promot.30.53%As ofSep 2026

Documents

1
Concall - Jan 2025 Jan 2025
2
Concall - Oct 2024 Oct 2024
3
Concall - May 2024 May 2024
4
Concall - May 2024 May 2024
5
Concall - Jun 2022 Jun 2022

Frequently Asked Questions about Ajooni Biotech

What does Ajooni Biotech Ltd do?
Incorporated in 2010, Ajooni Biotech Ltd is a vegetarian based animal health care solutions company.[1]
Where is Ajooni Biotech Ltd (AJOONI) listed?
Ajooni Biotech Ltd trades as AJOONI on the NSE.
Which sector does Ajooni Biotech Ltd belong to?
Ajooni Biotech Ltd is classified under the FMCG sector, in the Food - Processing - Indian industry.
What is the market capitalisation of Ajooni Biotech Ltd?
Ajooni Biotech Ltd has a market capitalisation of ₹50.81 Cr as of 29 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Ajooni Biotech Ltd?
Ajooni Biotech Ltd trades at a PE ratio of 12.83 as of 29 Oct 2026, on earnings per share of ₹0.23, against a book value of ₹5.24 per share.
What is the 52-week high and low of Ajooni Biotech Ltd?
Over the last 52 weeks Ajooni Biotech Ltd has traded between ₹2.68 and ₹5.5 as of 29 Oct 2026.
What is the Return on Equity (ROE) of Ajooni Biotech Ltd?
Ajooni Biotech Ltd reported a return on equity of 4.74%. Its debt-to-equity ratio is 0.20.

Company Information

Incorporated in 2010, Ajooni Biotech Ltd is a vegetarian based animal health care solutions company.[1]

Website ajoonibiotech.com
CEO Mr. Jasjot Singh
Employees 134
Listed 2018-01-02
Face Value ₹ 2
Shares Outstanding 17,22,43,598

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/AJOONI.md for Ajooni Biotech Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Food Processing stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month